Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
Add more filters










Publication year range
1.
Chemosphere ; 306: 135616, 2022 Nov.
Article in English | MEDLINE | ID: mdl-35810859

ABSTRACT

Environmental emission of pharmaceutical pollutants notably causes the contamination of aquatic ecosystems and drinking water. Typically, reduction of these pollutants in the environment is mostly managed by ameliorated wastewater treatments. Here, we report a method for the eco-design of drugs through the introduction within the molecular structure of a sensitive chemical group responsive to water treatments. The new drugs are thus programmed to fragment more easily and quickly than the original drugs. In this "retro catabolic drug design" strategy, methotrexate was used as drug model and an ether analog displaying a similar pharmacological profile was selected. Using photo-irradiation experiments at 254 nm, a representative drinking water treatment process, the identified transformation products were predominantly obtained from the expected molecular scission. Moreover, a faster kinetics of degradation was measured for the ether analog as compared to methotrexate and its transformation products were far less cytotoxic.


Subject(s)
Drinking Water , Environmental Pollutants , Water Pollutants, Chemical , Ecosystem , Ethers , Methotrexate/toxicity , Pharmaceutical Preparations , Photolysis , Wastewater , Water Pollutants, Chemical/analysis
2.
J Microencapsul ; 39(3): 239-251, 2022 May.
Article in English | MEDLINE | ID: mdl-35352611

ABSTRACT

AIMS: The aim of our work is to load Vinblastine drugs loaded on graphene quantum dots to improve its cytotoxicity on cancer cells and reduce it on the normal cell in the composites. Moreover, the GQDs-Vin composite significantly inhibited tumour growth in animals. METHODS: GQDs-Vin composites were prepared by homogenisation of GQDs and Vin solutions. The loading of Vin on GQDs in the composites was characterised by FTIR, PL, UV-vis spectra, and TEM. The cytotoxicity of GQDs, Vin, and GQDs-Vin composites was investigated on the Hela, HGC-27, A549, MCF-7, CCF-STTG1 cells and Vero by in vitro and in vivo methods. The difference in cellular structure and organelles in mice's livers in comparison between the control group and GQDs-Vin (1:5) groups was characterised by TEM. RESULTS: The diameter of the nanoparticles of GQDs-Vin composites in weight ratios 1:1, 1:3 and 1:5 w/w of 50-70 nm, 100-150 nm and ∼500nm, respectively, is larger than that of GQDs of 10-50nm. The in vitro results showed that GQDs not only improved the cytotoxicity of Vin to cancer cells but also decreased its cytotoxicity towards normal cells in the composites. The GQDs-Vin (1:5) composite exhibited a stronger tumour inhibition effect than Vin alone. The morphology of mice's livers showed the absence GQDs-Vin nanoparticles in the mice livers suggesting the lack of storage and the leakage from the liver without any toxicity. CONCLUSIONS: Results of the improved cytotoxicity of GQDs-Vin composite on cancer cells, its reduced cytotoxicity on normal cells and the significant inhibition on tumour growth of GQDs-Vin composite compared with Vin and GQDs alone may indicate a synergistic effect of Vin and GQDs in their composites for anticancer application.


Subject(s)
Graphite , Quantum Dots , Animals , Graphite/chemistry , Graphite/pharmacology , HeLa Cells , Humans , Mice , Quantum Dots/chemistry , Vinblastine
3.
Angew Chem Int Ed Engl ; 60(45): 24043-24047, 2021 11 02.
Article in English | MEDLINE | ID: mdl-34487611

ABSTRACT

Pharmacological inactivation of antitumor drugs toward healthy cells is a critical factor in prodrug development. Typically, pharmaceutical chemists graft temporary moieties to existing antitumor drugs to reduce their pharmacological activity. Here, we report a platform able to generate the cytotoxic agent by intramolecular cyclization. Using phenanthridines as cytotoxic model compounds, we designed ring-opened biaryl precursors that generated the phenanthridines through bioorthogonal irreversible imination. This reaction was triggered by reactive oxygen species, commonly overproduced in cancer cells, able to convert a vinyl boronate ester function into a ketone that subsequently reacted with a pendant aniline. An inactive precursor was shown to engender a cytotoxic phenanthridine against KB cancer cells. Moreover, the kinetic of cyclization of this prodrug was extremely rapid inside living cells of KB cancer spheroids so as to circumvent drug action.


Subject(s)
Antineoplastic Agents/pharmacology , Drug Development , Phenanthridines/pharmacology , Prodrugs/pharmacology , Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/chemistry , Cell Proliferation/drug effects , Cell Survival/drug effects , Cyclization , Drug Screening Assays, Antitumor , Humans , KB Cells , Molecular Structure , Phenanthridines/chemical synthesis , Phenanthridines/chemistry , Prodrugs/chemical synthesis , Prodrugs/chemistry
5.
Eur J Med Chem ; 207: 112670, 2020 Dec 01.
Article in English | MEDLINE | ID: mdl-32858470

ABSTRACT

Boronic acid (and ester) prodrugs targeting the overexpressed level of reactive oxygen species within tumor microenvironment represent a promising area for the discovery of new selective anticancer chemotherapy. This strategy that emerged only ten years ago is exponentially growing and could demonstrate its clinical usefulness in the near future. Herein, the previously described small-molecule and macromolecular anticancer prodrugs activated by carbon-boron oxidation are gathered. This review reports on the most interesting derivatives mentioned in the literature based on the in vitro and in vivo activity when available. Eventually, the pharmacological applicability of this strategy is discussed, in particular, the kinetic aspect of the prodrug oxidation and the selectivity of this reaction towards certain ROS from the tumor microenvironment are specified.


Subject(s)
Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , Boron Compounds/chemistry , Boron Compounds/pharmacology , Prodrugs/chemistry , Prodrugs/pharmacology , Animals , Antineoplastic Agents/therapeutic use , Boron Compounds/therapeutic use , Humans , Neoplasms/drug therapy , Neoplasms/metabolism , Oxidative Stress/drug effects , Prodrugs/therapeutic use , Reactive Oxygen Species/metabolism , Tumor Microenvironment/drug effects
6.
ACS Omega ; 5(18): 10466-10480, 2020 May 12.
Article in English | MEDLINE | ID: mdl-32426604

ABSTRACT

New Delhi metallo-ß-lactamase-1 (NDM-1) has recently emerged as a global threat because of its ability to confer resistance to all common ß-lactam antibiotics. Understanding the molecular basis of ß-lactam hydrolysis by NDM is crucial for designing NDM inhibitors or ß-lactams resistant to their hydrolysis. In this study, for the first time, NMR was used to study the influence of Zn(II) ions on the dynamic behavior of NDM-1. Our results highlighted that the binding of Zn(II) in the NDM-1 active site induced several structural and dynamic changes on active site loop 2 (ASL2) and L9 loops and on helix α2. We subsequently studied the interaction of several flavonols: morin, quercetin, and myricetin were identified as natural and specific inhibitors of NDM-1. Quercetin conjugates were also synthesized in an attempt to increase the solubility and bioavailability. Our NMR investigations on NDM-1/flavonol interactions highlighted that both Zn(II) ions and the residues of the NDM-1 ASL1, ASL2, and ASL4 loops are involved in the binding of flavonols. This is the first NMR interaction study of NDM-1/inhibitors, and the models generated using HADDOCK will be useful for the rational design of more active inhibitors, directed against NDM-1.

7.
Bioorg Med Chem Lett ; 29(14): 1710-1713, 2019 07 15.
Article in English | MEDLINE | ID: mdl-31122868

ABSTRACT

This study describes the synthesis of fluorescent probes as potential substrates for the polyamine transport system (PTS) of Leishmania donovani. A competitive radioassay was used to determine the most efficient probe. We observed that the conjugate spermine-nitrobenzofurazan (Spm-NBD) was able to compete with [3H]-spermidine in L. donovani at a potent IC50 of 60 µM.


Subject(s)
Biological Transport/physiology , Polyamines/metabolism , Spermine/chemical synthesis , Animals , Fluorescent Dyes , Leishmania donovani
8.
Eur J Med Chem ; 150: 655-666, 2018 Apr 25.
Article in English | MEDLINE | ID: mdl-29567458

ABSTRACT

This study describes the synthesis and the biological evaluation of twenty-four original bis(benzyl)spermidines. Structural modifications of the polyamine scaffold were performed in order to avoid easily metabolized bonds. Some bis(benzyl)polyamine derivatives have demonstrated promising activity in vitro against Trypanosoma brucei gambiense and Leishmania donovani. From the enzymatic experiments on trypanothione reductase, we observed that this enzyme was not targeted by our compounds. In vivo evaluation on Swiss mice model infected by T. b. gambiense or L. donovani was done with the most interesting compound of the series.


Subject(s)
Antiprotozoal Agents/pharmacology , Spermidine/pharmacology , Antiprotozoal Agents/chemical synthesis , Antiprotozoal Agents/chemistry , Dose-Response Relationship, Drug , Leishmania donovani , Molecular Structure , Parasitic Sensitivity Tests , Spermidine/chemical synthesis , Spermidine/chemistry , Structure-Activity Relationship , Trypanosoma brucei gambiense
9.
Eur J Med Chem ; 139: 982-1015, 2017 Oct 20.
Article in English | MEDLINE | ID: mdl-28886510

ABSTRACT

Naturally occurring polyamines: putrescine, spermidine and spermine are crucial for Kinetoplastid growth and persistence. These aliphatic polycations are either biosynthesized or internalized into Kinetoplastid by active transport. Impairing the polyamine metabolism using polyamine derivatives is an interesting path in the search of new antikinetoplastid chemotherapy. In the past 30 years, research interest in this field has been constantly expanding and recent results demonstrated that the discovery of a polyamine-based antikinetoplastid drug is undoubtedly possible. In this paper, all the polyamine derivatives previously described to present an antikinetoplastid activity are reported. This review is organized around three main parts which are diamine, triamine and tetramine derivatives. Each part includes the description of the series of molecules and, their in vitro and in vivo activity when available. Structure-activity relationships of these derivatives are discussed and the most promising structures for a positive outcome are eventually highlighted.


Subject(s)
Antiprotozoal Agents/pharmacology , Kinetoplastida/drug effects , Polyamines/pharmacology , Animals , Antiprotozoal Agents/chemical synthesis , Antiprotozoal Agents/chemistry , Dose-Response Relationship, Drug , Humans , Kinetoplastida/metabolism , Molecular Structure , Parasitic Sensitivity Tests , Polyamines/chemical synthesis , Polyamines/chemistry , Structure-Activity Relationship
10.
Bioorg Med Chem ; 25(1): 84-90, 2017 01 01.
Article in English | MEDLINE | ID: mdl-27793448

ABSTRACT

Thirteen new polyamine derivatives coupled to hydroxybenzotriazole have been synthesized and evaluated for their in vitro antikinetoplastid activity. Trypanosoma Trypanothione reductase (TryR) was envisioned as a potential target. Among all tested molecules, only one compound, a N3-spermidine-benzotriazole derivative, displayed relevant inhibitory activity on this enzyme but was not active on parasites. The corresponding Boc-protected spermidine-benzotriazole was however trypanocidal against Trypanosoma brucei gambiense with an IC50 value of 1µM and was completely devoid of cytotoxicity. On the intramacrophage amastigotes of Leishmania donovani, a N2-spermidine conjugate of this series, exhibited an interesting IC50 value of 3µM associated with both low cytotoxicity against axenic Leishmania donovani. These new compounds are promising leads for the development of antikinetoplastid agents and their targets have to be deciphered.


Subject(s)
Antiprotozoal Agents/chemistry , Antiprotozoal Agents/pharmacology , Leishmania donovani/drug effects , Triazoles/chemistry , Triazoles/pharmacology , Trypanosoma brucei brucei/drug effects , Animals , Antiprotozoal Agents/chemical synthesis , Humans , Leishmania donovani/enzymology , Leishmaniasis, Visceral/drug therapy , NADH, NADPH Oxidoreductases/antagonists & inhibitors , NADH, NADPH Oxidoreductases/metabolism , Spermidine/analogs & derivatives , Spermidine/chemical synthesis , Spermidine/pharmacology , Triazoles/chemical synthesis , Trypanocidal Agents/chemical synthesis , Trypanocidal Agents/chemistry , Trypanocidal Agents/pharmacology , Trypanosoma brucei brucei/enzymology , Trypanosomiasis, African/drug therapy
11.
Bioorg Med Chem Lett ; 25(2): 207-9, 2015 Jan 15.
Article in English | MEDLINE | ID: mdl-25499437

ABSTRACT

A structure-activity relationship study on polyamine derivatives led to the synthesis and the determination of antikinetoplastid activity of 17 compounds. Among them, a spermidine derivative (compound 13) was specifically active in vitro against Leishmania donovani axenic amastigotes (IC50 at 5.4µM; Selectivity Index >18.5) and a spermine derivative (compound 28) specifically active against Trypanosoma brucei gambiense (IC50 at 1.9µM; Selectivity Index >52).


Subject(s)
Antiprotozoal Agents/chemical synthesis , Drug Design , Kinetoplastida/drug effects , Putrescine/chemical synthesis , Spermidine/chemical synthesis , Spermine/chemical synthesis , Acylation , Antiprotozoal Agents/pharmacology , Drug Evaluation, Preclinical/methods , Leishmania donovani/drug effects , Putrescine/pharmacology , Spermidine/pharmacology , Spermine/pharmacology , Trypanosoma brucei brucei/drug effects
12.
ChemMedChem ; 7(4): 587-605, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22331612

ABSTRACT

New N-alkylaminoacridine derivatives attached to nitrogen heterocycles were synthesized, and their antimalarial potency was examined. They were tested in vitro against the growth of Plasmodium falciparum, including chloroquine (CQ)-susceptible and CQ-resistant strains. This biological evaluation has shown that the presence of a heterocyclic ring significantly increases the activity against P. falciparum. The best compound shows a nanomolar IC(50) value toward parasite proliferation on both CQ-susceptible and CQ-resistant strains. The antimalarial activity of these new acridine derivatives can be explained by the two mechanisms studied in this work. First, we showed the capacity of these compounds to inhibit heme biocrystallization, a detoxification process specific to the parasite and essential for its survival. Second, in our search for alternative targets, we evaluated the in vitro inhibitory activity of these compounds toward Sulfolobus shibatae topoisomerase VI-mediated DNA relaxation. The preliminary results obtained reveal that all tested compounds are potent DNA intercalators, and significantly inhibit the activity of S. shibatae topoisomerase VI at concentrations ranging between 2.0 and 2.5 µM.


Subject(s)
Acridines/chemistry , Antimalarials/chemical synthesis , Antimalarials/pharmacology , Aminacrine/chemistry , Antimalarials/chemistry , Antimalarials/pharmacokinetics , Cell Line , Chloroquine/pharmacology , Dose-Response Relationship, Drug , Drug Evaluation, Preclinical/methods , Drug Resistance, Microbial , Heme/metabolism , Hemeproteins/antagonists & inhibitors , Humans , Hydrogen-Ion Concentration , Inhibitory Concentration 50 , KB Cells/drug effects , Molecular Structure , Plasmodium falciparum/drug effects , Plasmodium falciparum/growth & development , Sulfolobus/enzymology , Topoisomerase Inhibitors/chemistry , Topoisomerase Inhibitors/pharmacology
13.
Bioorg Med Chem ; 17(23): 8032-9, 2009 Dec 01.
Article in English | MEDLINE | ID: mdl-19879150

ABSTRACT

A series of acridine derivatives were synthesised and their in vitro antimalarial activity was evaluated against one chloroquine-susceptible strain (3D7) and three chloroquine-resistant strains (W2, Bre1 and FCR3) of Plasmodium falciparum. Structure-activity relationship showed that two positives charges as well as 6-chloro and 2-methoxy substituents on the acridine ring were required to exert a good antimalarial activity. The best compounds possessing these features inhibited the growth of the chloroquine-susceptible strain with an IC(50)0.07 microM, close to that of chloroquine itself, and that of the three chloroquine-resistant strains better than chloroquine with IC(50)0.3 microM. These acridine derivatives inhibited the formation of beta-hematin, suggesting that, like CQ, they act on the haem crystallization process. Finally, in vitro cytotoxicity was also evaluated upon human KB cells, which showed that one of them 9-(6-ammonioethylamino)-6-chloro-2-methoxyacridinium dichloride 1 displayed a promising antimalarial activity in vitro with a quite good selectivity index versus mammalian cell on the CQ-susceptible strain and promising selectivity on other strains.


Subject(s)
Aminoacridines/chemical synthesis , Antimalarials/chemical synthesis , Hemin/metabolism , Malaria, Falciparum/drug therapy , Plasmodium falciparum/growth & development , Aminoacridines/chemistry , Aminoacridines/pharmacology , Antimalarials/chemistry , Antimalarials/pharmacology , Cell Line, Tumor , Cell Survival/drug effects , Humans , Inhibitory Concentration 50 , Magnetic Resonance Spectroscopy , Mass Spectrometry , Spectrophotometry, Ultraviolet , Structure-Activity Relationship
14.
Cell Signal ; 20(11): 2119-26, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18761085

ABSTRACT

Ras GTPase-activating protein (RasGAP) is hypothesized to be an effector of oncogenic Ras stimulating numerous downstream cellular signaling cascades involved in survival, proliferation and motility. In this study, we identified calpain small subunit-1 (Capns1) as a new RasGAP-SH3 domain binding partner, using yeast two-hybrid screening. The interaction was confirmed by co-immunoprecipitation assay and was found specific to cells expressing oncogenic K-Ras. We used confocal microscopy to analyze our stably transfected cell model producing mutant Ras (PC3Ras(V12)). Staining for RasGAP-SH3/Capns1 co-localization was two-fold stronger in the protrusions of Ras(V12) cells than in PC3 cells. RasGAP or Capns1 knockdown in PC3Ras(V12) cells induced a two- to three-fold increase in apoptosis. Capns1 gene silencing reduced the speed and increased the persistence of movement in PC3Ras(V12) cells. In contrast, RasGAP knockdown in PC3Ras(V12) cells increased cell migration. Knockdown of both proteins altered the speed and directionality of cell motility. Our findings suggest that RasGAP and Capns1 interaction in oncogenic Ras cells is involved in regulating migration and cell survival.


Subject(s)
Calpain/metabolism , Cell Movement , Genes, ras , ras GTPase-Activating Proteins/chemistry , ras GTPase-Activating Proteins/metabolism , Animals , Apoptosis , Catalysis , Cell Line, Tumor , Cell Survival , Drosophila , Drosophila Proteins/metabolism , Humans , Protein Binding , Protein Subunits/metabolism , Protein Transport , Sequence Homology, Amino Acid , Two-Hybrid System Techniques , src Homology Domains
15.
Biochemistry ; 46(45): 13080-8, 2007 Nov 13.
Article in English | MEDLINE | ID: mdl-17956127

ABSTRACT

Flavocytochrome b2, a flavohemoprotein, catalyzes the oxidation of lactate at the expense of the physiological acceptor cytochrome c in the yeast mitochondrial intermembrane space. The mechanism of electron transfer from the substrate to monoelectronic acceptors via FMN and heme b2 has been intensively studied over the years. Each prosthetic group is bound to a separate domain, N-terminal for the heme, C-terminal for the flavin. Each domain belongs to a distinct evolutionary family. In particular, the flavodehydrogenase domain is homologous to a number of well-characterized l-2-hydroxy acid-oxidizing enzymes. Among these, some are oxidases for which the oxidative half-reaction produces hydrogen peroxide at the expense of oxygen. For bacterial mandelate dehydrogenase and flavocytochrome b2, in contrast, the oxidative half-reaction requires monoelectronic acceptors. Several crystal structures indicate an identical fold and a highly conserved active site among family members. All these enzymes form anionic semiquinones and bind sulfite, properties generally associated with oxidases, whereas electron transferases are expected to form neutral semiquinones and to yield superoxide anion. Thus, flavocytochrome b2 is a highly unusual dehydrogenase-electron transferase, and one may wonder how its flavin reacts with oxygen. In this work, we show that the separately engineered flavodehydrogenase domain produces superoxide anion in its slow reaction with oxygen. This reaction apparently also takes place in the holoenzyme when oxygen is the sole electron acceptor, because the heme domain autoxidation is also slow; this is not unexpected, in view of the heme domain mobility relative to the tetrameric flavodehydrogenase core (Xia, Z. X., and Mathews, F. S. (1990) J. Mol. Biol. 212, 837-863). Nevertheless, this reaction is so slow that it cannot compete with the normal electron flow in the presence of monoelectronic acceptors, such as ferricyanide and cytochrome c. An inspection of the available structures of family members does not provide a rationale for the difference between the oxidases and the electron transferases.


Subject(s)
Cytochrome b Group/chemistry , Flavins/chemistry , NADPH Oxidases/chemistry , Oxygen/chemistry , Alcohol Oxidoreductases/metabolism , Hydrogen Peroxide/metabolism , Lactic Acid/metabolism , Saccharomyces cerevisiae/enzymology
16.
J Med Chem ; 49(15): 4657-64, 2006 Jul 27.
Article in English | MEDLINE | ID: mdl-16854071

ABSTRACT

We have designed, synthesized, and evaluated the inhibitory activity and metabolic stability of new peptidomimetic molecular tongs based on a naphthalene scaffold for inhibiting HIV-1 protease dimerization. Peptidomimetic motifs were inserted into one peptidic strand to make it resistant to proteolysis. The peptidic character of the molecular tongs can be decreased without changing the way they inhibit dimerization. Mutated HIV-1 proteases are also vulnerable to dimerization inhibitors, and the multimutated protease ANAM-11 is twice as sensitive to the inhibitor compared to wild-type protease. Thus, the metabolic stability of antidimeric molecular tongs can be increased without compromising their ability to inhibit wild-type and mutated HIV-1 proteases in vitro.


Subject(s)
Amino Acids/chemistry , HIV Protease Inhibitors/chemistry , HIV Protease/chemistry , Dimerization , Drug Stability , HIV Protease/chemical synthesis , HIV Protease/genetics , HIV Protease Inhibitors/chemical synthesis , Hydrolysis , Models, Molecular , Molecular Conformation , Molecular Mimicry , Mutation , Naphthalenes/chemical synthesis , Naphthalenes/chemistry , Peptides/chemistry , Pyridines/chemical synthesis , Pyridines/chemistry
17.
Bioorg Med Chem ; 13(7): 2373-9, 2005 Apr 01.
Article in English | MEDLINE | ID: mdl-15755639

ABSTRACT

Recent studies have demonstrated that arginase plays important roles in pathologies such as asthma or erectile dysfunctions. We have synthesized new omega-borono-alpha-amino acids that are analogues of the previously known arginase inhibitors S-(2-boronoethyl)-l-cysteine (BEC) and 2-amino-6-boronohexanoic acid (ABH) and evaluated them as inhibitors of purified rat liver arginase (RLA). In addition to the distance between the B(OH)(2) and the alpha-amino acid functions, the position of the sulfur atom in the side chain also appears as a key determinant for the interaction with the active site of RLA. Furthermore, substitution of the alkyl side chain of BEC by methyl groups and conformational restriction of ABH by incorporation of its side chain in a phenyl ring led to inactive compounds. These results suggest that subtle interactions govern the affinity of inhibitors for the active site of RLA.


Subject(s)
Amino Acids/chemical synthesis , Amino Acids/pharmacology , Arginase/antagonists & inhibitors , Boron Compounds/chemistry , Enzyme Inhibitors/chemical synthesis , Enzyme Inhibitors/pharmacology , Amino Acids/chemistry , Animals , Arginase/metabolism , Enzyme Inhibitors/chemistry , Liver/enzymology , Liver/metabolism , Male , Molecular Structure , Rats , Rats, Sprague-Dawley , Structure-Activity Relationship
18.
Biochemistry ; 43(28): 8987-99, 2004 Jul 20.
Article in English | MEDLINE | ID: mdl-15248756

ABSTRACT

Arginase is a manganese metalloenzyme that catalyzes the hydrolysis of L-arginine to form L-ornithine and urea. The structure and stability of the binuclear manganese cluster are critical for catalytic activity as it activates the catalytic nucleophile, metal-bridging hydroxide ion, and stabilizes the tetrahedral intermediate and its flanking states. Here, we report X-ray structures of a series of inhibitors bound to the active site of arginase, and each inhibitor exploits a different mode of coordination with the Mn(2+)(2) cluster. Specifically, we have studied the binding of fluoride ion (F(-); an uncompetitive inhibitor) and L-arginine, L-valine, dinor-N(omega)-hydroxy-L-arginine, descarboxy-nor-N(omega)-hydroxy-L-arginine, and dehydro-2(S)-amino-6-boronohexanoic acid. Some inhibitors, such as fluoride ion, dinor-N(omega)-hydroxy-L-arginine, and dehydro-2(S)-amino-6-boronohexanoic acid, cause the net addition of one ligand to the Mn(2+)(2) cluster. Other inhibitors, such as descarboxy-nor-N(omega)-hydroxy-L-arginine, simply displace the metal-bridging hydroxide ion of the native enzyme and do not cause any net change in the metal coordination polyhedra. The highest affinity inhibitors displace the metal-bridging hydroxide ion (and sometimes occupy a Mn(2+)(A) site found vacant in the native enzyme) and maintain a conserved array of hydrogen bonds with their alpha-amino and -carboxylate groups.


Subject(s)
Arginase/chemistry , Enzyme Inhibitors/chemistry , Manganese , Animals , Arginase/antagonists & inhibitors , Arginine/analogs & derivatives , Arginine/chemistry , Binding Sites , Crystallography, X-Ray , Fluorine/chemistry , Hydrogen Bonding , Metalloproteins/antagonists & inhibitors , Metalloproteins/chemistry , Molecular Structure , Protein Binding , Rats , Recombinant Proteins , Valine/chemistry
19.
J Inorg Biochem ; 88(3-4): 397-402, 2002 Feb.
Article in English | MEDLINE | ID: mdl-11897356

ABSTRACT

The inhibitory effects of anions, such as N(3)(-), NO(2)(-), BO(4)(3-), SCN(-), CH(3)COO(-), SO(4)(2-), ClO(4)(-), H(2)PO(4)(-), CN(-), I(-), Br(-), Cl(-) and F(-), on the hydrolysis of L-arginine (L-Arg) by rat liver arginase (RLA) have been studied. From all these anions, only F(-) exhibited a clear inhibitory effect at the mM level. Inhibition of RLA by F(-) is reversible and uncompetitive towards L-Arg binding with a K(i) value of 1.3+/-0.5 mM at pH 7.4. This effect is dependent on pH as the IC(50) value of F(-) towards RLA increases from 1.2 to 19 mM when increasing the pH from 7 to 10. Another specific inhibitor of RLA, N(omega)-hydroxy-L-nor-arginine (nor-NOHA), that has been recently shown to bind to RLA as a bridging ligand of its (Mn(II))(2) cluster, exhibits some similarities with F(-) in its inhibitory effects (identical pH dependence). It is thus tempting to propose that the inhibitory effects of F(-) could be due to its binding as a bridging ligand of the RLA (Mn(II))(2) cluster. However, further studies are required to determine the modes of interaction of F(-) with RLA.


Subject(s)
Arginase/antagonists & inhibitors , Fluorides/pharmacology , Liver/enzymology , Animals , Anions , Arginine/chemistry , Enzyme Inhibitors/pharmacology , Hydrogen-Ion Concentration , Liver/drug effects , Male , Models, Molecular , Rats , Rats, Sprague-Dawley
SELECTION OF CITATIONS
SEARCH DETAIL
...